Beryl Drugs Ltd

BERLDRG Share Price

BSE

₹18.860.63% (-0.12)

Health Care

Pharmaceuticals

Smallcap

With a market cap of ₹10 cr, stock is ranked 4,842

High Risk

Stock is 4.29x as volatile as Nifty

BERLDRG Stock Scorecard

Performance

Avg

Price return has been average, nothing exciting

Valuation

High

Seems to be overvalued vs the market average

Growth

Low

Lagging behind the market in financials growth

Profitability

Avg

Average profitability - not good, not bad

Entry point

Avg

The stock is not in the overbought zone

Red flags

Avg

The stock has a moderate number of red flags

How to use scorecard? Learn more

Health Care

Pharmaceuticals

Smallcap

With a market cap of ₹10 cr, stock is ranked 4,842

High Risk

Stock is 4.29x as volatile as Nifty

BERLDRG Performance & Key Metrics

No LabelNo Label	PB RatioPB Ratio	Dividend YieldDiv. Yield
345.38	1.09	—

Sector PESector PE	Sector PBSector PB	Sector Div YldSctr Div Yld
34.78	5.49	0.61%

BERLDRG Analyst Ratings & Forecast

—

Analyst Ratings data is currently unavailable for this stock

Price Upside

Earnings Growth

Rev. Growth

BERLDRG Company Profile

Beryl Drugs is engaged in the manufacturing of allopathic pharmaceuticals preparations.

BERLDRG Similar Stocks (Peers)

Compare with peers Compare with peers

BERLDRG Similar Stocks (Peers)

Compare with peers Compare with peers

Sun Pharmaceutical Industries Ltd

SUNPHARMA

PE Ratio

38.60

1Y Return

1.17%

Buy Reco %

94.12

Torrent Pharmaceuticals Ltd

TORNTPHARM

PE Ratio

74.62

1Y Return

24.32%

Buy Reco %

78.57

Lupin Ltd

LUPIN

PE Ratio

31.99

1Y Return

13.18%

Buy Reco %

72.22

Dr Reddy's Laboratories Ltd

DRREDDY

PE Ratio

18.45

1Y Return

5.85%

Buy Reco %

51.61

Cipla Ltd

CIPLA

PE Ratio

18.72

1Y Return

17.90%

Buy Reco %

51.61

Compare with Peers

BERLDRG Forecast

BERLDRG Forecasts

BERLDRG

Income

Balance Sheet

Cash Flow

Financial Year		FY 2017		FY 2018		FY 2019		FY 2020		FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	TTM
Total Revenue	11.39	15.87	13.20	13.05	14.73	14.76	27.16	27.13	22.56	19.07
Raw Materials	6.94	8.83	6.85	0.94	0.76	0.90	1.25	1.48	1.12	17.47
Power & Fuel Cost	0.90	1.04	1.06	0.77	0.86	0.85	1.27	1.54	1.25
Employee Cost	1.01	0.77	0.85	0.97	1.18	1.31	1.70	1.93	2.21
Selling & Administrative Expenses	1.22	2.18	2.06	2.24	1.92	2.16	4.50	4.64	2.89
Operating & Other expenses	1.10	1.33	1.12	6.99	7.92	8.96	16.17	14.85	12.44
EBITDA	0.22	1.72	1.26	1.14	2.09	0.58	2.27	2.69	2.65	1.60
Depreciation/Amortization	0.38	0.33	0.32	0.66	1.27	1.09	0.81	1.20	1.25	1.41
PBIT	-0.16	1.39	0.94	0.48	0.82	-0.51	1.46	1.49	1.40	0.19
Interest & Other Items	0.20	0.13	0.15	0.32	0.47	0.46	0.47	0.47	0.54	0.35
PBT	-0.36	1.26	0.79	0.16	0.35	-0.97	0.99	1.02	0.86	-0.16
Taxes & Other Items	0.07	0.28	0.21	0.11	0.11	-0.29	0.22	0.24	0.29	-0.19
Net Income	-0.43	0.98	0.58	0.05	0.24	-0.68	0.77	0.78	0.57	0.03
EPS	-0.84	1.92	1.14	0.10	0.47	-1.33	1.50	1.52	1.11	0.06
DPS	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Payout ratio	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00

BERLDRG Income Statement

Quarter		sep 2023		dec 2023		mar 2024		jun 2024		sep 2024	dec 2024	mar 2025	jun 2025	sep 2025	dec 2025
Total Revenue	8.09	7.66	3.21	6.29	5.65	5.40	5.22	4.84	5.16	3.85
Operating & Other expenses	7.37	6.86	3.18	5.30	5.08	4.81	4.72	4.28	4.42	4.05
EBITDA	0.72	0.80	0.03	0.99	0.57	0.59	0.50	0.56	0.74	-0.20
Depreciation/Amortization	0.29	0.31	0.32	0.28	0.33	0.31	0.32	0.38	0.39	0.32
PBIT	0.43	0.49	-0.29	0.71	0.24	0.28	0.18	0.18	0.35	-0.52
Interest & Other Items	0.10	0.11	0.13	0.21	0.12	0.12	0.08	0.10	0.08	0.09
PBT	0.33	0.38	-0.42	0.50	0.12	0.16	0.10	0.08	0.27	-0.61
Taxes & Other Items	0.06	0.06	-0.07	0.13	0.10	0.10	-0.05	0.05	0.25	-0.44
Net Income	0.27	0.32	-0.35	0.37	0.02	0.06	0.15	0.03	0.02	-0.17
EPS	0.54	0.61	-0.68	0.73	0.01	0.10	0.30	0.04	0.02	-0.33

Financial Year		FY 2016		FY 2017		FY 2018		FY 2019		FY 2020	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025
Cash from Operating Activities	-0.13	0.37	-0.10	3.35	0.18	0.34	-0.29	2.48	0.82	2.64
Cash from Investing Activities	0.17	0.32	-0.03	-5.01	-1.55	0.26	0.54	-1.30	-1.08	-0.40
Cash from Financing Activities	-0.23	-0.19	-0.36	1.62	1.67	-0.54	-0.43	-1.17	0.10	-1.55
Net Change in Cash	-0.19	+0.50	-0.49	-0.04	+0.30	+0.06	-0.18	+0.01	-0.16	+0.69
Changes in Working Capital	-1.05	+0.65	-0.98	+2.27	-0.81	-1.15	-0.73	+0.39	-1.71	+0.14
Capital Expenditures	0.20	0.20	0.30	0.09	1.88	1.05	0.42	1.56	1.35	2.19
Free Cash Flow	-0.33	0.17	-0.40	3.26	-1.70	-0.71	-0.71	0.92	-0.53	0.45

BERLDRG Company Updates

FY 2025FY 2025

Annual report

PDF

FY 2024FY 2024

Annual report

PDF

FY 2023FY 2023

Annual report

PDF

FY 2022FY 2022

Annual report

PDF

FY 2021FY 2021

Annual report

PDF

FY 2020FY 2020

Annual report

PDF

FY 2019FY 2019

Annual report

PDF

FY 2018FY 2018

Annual report

PDF

FY 2017FY 2017

Annual report

PDF

FY 2016FY 2016

Annual report

PDF

BERLDRG Stock Peers

BERLDRG Past Performance & Peer Comparison

Comparing 3 stocks from
Health CarePharmaceuticals

Valuation

Technical

Forecast

Compare valuation on Screener

Stock	PE RatioPE Ratio	PB RatioPB Ratio	Div. YieldDividend Yield
Beryl Drugs Ltd	18.18	1.09	—
Sun Pharmaceutical Industries Ltd	38.60	5.82	0.91%
Torrent Pharmaceuticals Ltd	74.62	18.79	0.76%
Lupin Ltd	31.99	6.07	0.52%

BERLDRG Stock Price Comparison

Compare BERLDRG with any stock or ETF

BERLDRG

BERLDRG Holdings

BERLDRG Shareholdings

BERLDRG Promoter Holdings Trend

BERLDRG Institutional Holdings Trend

BERLDRG Shareholding Pattern

BERLDRG Shareholding History

Foreign Institutions

BERLDRG Insider Trades & Bulk Stock Deals

smallcases containing BERLDRG stock

Looks like this stock is not in any smallcase yet.

BERLDRG Events

BERLDRG Dividend Trend

Dividends

Corp. Actions

Announcements

Legal Orders

BERLDRG Dividend Trend

BERLDRG Dividends

Hmm, looks like data is unavailable here. Please come back after some time

BERLDRG Corp. Actions

Hmm, looks like data is unavailable here. Please come back after some time

No upcoming announcements are available

Company Update

Announced OnApr 3, 2026

Beryl Drugs Ltd - 524606 - Announcement

Beryl Drugs Ltd - 524606 - Announcement Download

Link

Download

Announced On

Apr 3, 2026

Corp. Action

Announced OnApr 1, 2026

Beryl Drugs Ltd - 524606 - FIXES RECORD

Beryl Drugs Ltd - 524606 - FIXES RECORD Download

Link

Download

Announced On

Apr 1, 2026

Company Update

Announced OnApr 1, 2026

Beryl Drugs Ltd - 524606 - INTIMATION OF

Beryl Drugs Ltd - 524606 - INTIMATION OF Download

Link

Download

Announced On

Apr 1, 2026

AGM/EGM

Announced OnApr 1, 2026

Beryl Drugs Ltd - 524606 - EGM ON 11TH M

Beryl Drugs Ltd - 524606 - EGM ON 11TH M Download

Link

Download

Announced On

Apr 1, 2026

Corp. Action

Announced OnApr 1, 2026

Beryl Drugs Ltd - 524606 - FIXES RECORD

Beryl Drugs Ltd - 524606 - FIXES RECORD Download

Link

Download

Announced On

Apr 1, 2026

BERLDRG Legal Orders

Hmm, looks like data is unavailable here. Please come back after some time

BERLDRG Stock News & Opinions

Corporate

Beryl Drugs schedules EGM

Beryl Drugs announced that an Extra Ordinary General Meeting (EGM) of the Company will be held on 11 May 2026.

1 day agoCapital Market - Live

Corporate

Beryl Drugs to convene board meeting

Beryl Drugs will hold a meeting of the Board of Directors of the Company on 1 April 2026.Powered by Capital Market - Live

2 weeks agoCapital Market - Live

Corporate

Beryl Drugs EGM scheduled

Beryl Drugs announced that an Extra Ordinary General Meeting (EGM) of the Company will be held on 16 March 2026.Powered by Capital Market - Live

1 month agoCapital Market - Live

Earnings

Beryl Drugs reports standalone net loss of Rs 0.17 crore in the December 2025 quarter

Net loss of Beryl Drugs reported to Rs 0.17 crore in the quarter ended December 2025 as against net profit of Rs 0.05 crore during the previous quarter ended December 2024. Sales declined 28.81% to Rs 3.78 crore in the quarter ended December 2025 as against Rs 5.31 crore during the previous quarter ended December 2024. ParticularsQuarter EndedDec. 2025Dec. 2024% Var. Sales3.785.31 -29 OPM %-5.2910.92 - PBDT-0.290.46 PL PBT-0.610.15 PL NP-0.170.05 PL Powered by Capital Market - Live

1 month agoCapital Market - Live

Corporate

Beryl Drugs to conduct board meeting

Beryl Drugs will hold a meeting of the Board of Directors of the Company on 9 February 2026.Powered by Capital Market - Live

2 months agoCapital Market - Live

Corporate

Beryl Drugs schedules board meeting

Beryl Drugs will hold a meeting of the Board of Directors of the Company on 3 January 2026.Powered by Capital Market - Live

3 months agoCapital Market - Live

Earnings

Beryl Drugs reports standalone net profit of Rs 0.01 crore in the September 2025 quarter

Net profit of Beryl Drugs remain constant at Rs 0.01 crore in the quarter ended September 2025 and also during the previous quarter ended September 2024. Sales declined 8.73% to Rs 5.12 crore in the quarter ended September 2025 as against Rs 5.61 crore during the previous quarter ended September 2024. ParticularsQuarter EndedSep. 2025Sep. 2024% Var. Sales5.125.61 -9 OPM %14.269.98 - PBDT0.650.44 48 PBT0.260.11 136 NP0.010.01 0 Powered by Capital Market - Live

4 months agoCapital Market - Live

Corporate

Beryl Drugs to announce Quarterly Result

Beryl Drugs will hold a meeting of the Board of Directors of the Company on 13 November 2025.Powered by Capital Market - Live

4 months agoCapital Market - Live

Corporate

Beryl Drugs schedules AGM

Beryl Drugs announced that the Annual General Meeting(AGM) of the company will be held on 30 September 2025.Powered by Capital Market - Live

7 months agoCapital Market - Live

Corporate

Beryl Drugs to hold board meeting

Beryl Drugs will hold a meeting of the Board of Directors of the Company on 2 September 2025.Powered by Capital Market - Live

7 months agoCapital Market - Live

Frequently asked questions

What is the share price of Beryl Drugs Ltd (BERLDRG) today?
The share price of BERLDRG as on 2nd April 2026 is ₹18.86. The stock prices are volatile and keep changing through the day depending upon various factors and market conditions.
What is the return on Beryl Drugs Ltd (BERLDRG) share?
The past returns of Beryl Drugs Ltd (BERLDRG) share are
- Past 1 week: -5.18%
- Past 1 month: -8.84%
- Past 3 months: -18.02%
- Past 6 months: -18.72%
- Past 1 year: -16.15%
- Past 3 years: 56.74%
- Past 5 years: 188.35%
What are the peers or stocks similar to Beryl Drugs Ltd (BERLDRG)?
The peers or stocks similar to Beryl Drugs Ltd (BERLDRG) include:
What is the market cap of Beryl Drugs Ltd (BERLDRG) share?
Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Beryl Drugs Ltd (BERLDRG) is ₹10.36 Cr as of 2nd April 2026.
What is the 52 week high and low of Beryl Drugs Ltd (BERLDRG) share?
The 52-week high of Beryl Drugs Ltd (BERLDRG) is ₹30 and the 52-week low is ₹15.92.
What is the PE and PB ratio of Beryl Drugs Ltd (BERLDRG) stock?
The P/E (price-to-earnings) ratio of Beryl Drugs Ltd (BERLDRG) is 18.18. The P/B (price-to-book) ratio is 1.09.
Which sector does Beryl Drugs Ltd (BERLDRG) belong to?
Beryl Drugs Ltd (BERLDRG) belongs to the Health Care sector & Pharmaceuticals sub-sector.
How to buy Beryl Drugs Ltd (BERLDRG) shares?
You can directly buy Beryl Drugs Ltd (BERLDRG) shares on Tickertape. Simply sign up, connect your demat account and place your order.

Stock	VolatilityVolatility	RSI–14DRSI – 14D	Price Mom RankPrice Momentum Rank
Beryl Drugs Ltd	58.12%	60.93	Pro
Sun Pharmaceutical Industries Ltd	19.76%	51.27
Torrent Pharmaceuticals Ltd	21.38%	37.73
Lupin Ltd	22.91%	48.04

Beryl Drugs Ltd

BERLDRG Share Price

BERLDRG Stock Scorecard

BERLDRG Performance & Key Metrics

BERLDRG Performance & Key Metrics

BERLDRG Analyst Ratings & Forecast

Price Upside

Earnings Growth

Rev. Growth

BERLDRG Company Profile

BERLDRG Similar Stocks (Peers)

BERLDRG Similar Stocks (Peers)

BERLDRG Forecast

BERLDRG Forecasts

BERLDRG